Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.49 |
| ▸ | CA7 | P43166 | 4/20 | 0.49 |
| ▸ | CA9 | Q16790 | 4/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.49 |
| ▸ | CA4 | P22748 | 3/20 | 0.49 |
| ▸ | CA6 | P23280 | 3/20 | 0.49 |
| ▸ | CA5A | P35218 | 3/20 | 0.49 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.49 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.49 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.49 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | CA3 | P07451 | 1/20 | 0.49 |
| ▸ | TYR | P14679 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL28794400 | 0.83 | HCAR2 (0.63) | CA12CA7CA9CA14CA4 | |
| Coumaric Acid SCHEMBL5145297 | 0.83 | CA12 (0.60) | CA12CA7CA9CA14CA4 | |
| Juarezic Acid SCHEMBL4085006 | 0.82 | LMNA (0.52) | CA12CA7CA9CA14CA4 | |
| SCHEMBL254038 | 0.82 | ALDH1A1 (0.50) | THRBMAPK1ALDH1A1 | |
| SCHEMBL711361 | 0.81 | ALDH1A1 (0.41) | CA12CA7CA9CA14CA4 | |
| SCHEMBL12691889 | 0.81 | CA12 (0.48) | CA12CA7CA9CA14CA4 | |
| SCHEMBL3437326 | 0.81 | CA12 (0.45) | CA12CA7CA9CA14CA4 | |
| SCHEMBL12171645 | 0.80 | THRB (0.53) | CA12CA7CA9CA14CA4 | |
| SCHEMBL1333067 | 0.79 | HCAR2 (0.49) | CA12CA7CA9CA14CA4 | |
| Crotonic Acid SCHEMBL28794401 | 0.79 | HCAR2 (0.54) | CA12CA7CA9CA14CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8753686-B2 | Surface-treating agents, surface-treated powders, and cosmetics comprising the same | SHISEIDO CO., LTD. (JP) | 2014-06-17 | — | — | US | disclosed |
| US-20110280946-A1 | Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same | SHISEIDO CO., LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| EP-2112179-B1 | Surface-treated powders, and cosmetics comprising the same | SHISEIDO CO LTD (JP) | 2011-04-27 | — | — | EP | disclosed |
| EP-1803750-B1 | USE OF A POLYMER FOR SURFACE-TREATING A POWDER | SHISEIDO CO LTD (JP) | 2009-12-09 | — | — | EP | disclosed |
| EP-2112179-A1 | Surface-treated powders, and cosmetics comprising the same | Shiseido Co., Ltd. (JP) | 2009-10-28 | — | — | EP | disclosed |
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | SHISEIDO CO., LTD. (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1803750-A1 | SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME | Shiseido Company, Limited (JP) | 2007-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | CHRM1, H1-0, H1-2 | CA12 2086/4885CA7 2607/4885CA9 4152/4885 |
| US-20110280946-A1 | Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same | CHRM1, H1-0, H1-2 | CA12 740/4885CA7 1422/4885CA9 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.